Institutional Ownership
Corbus Pharmaceuticals Hldgs
CUSIP 21833P301COM NEWCRBPQ1 2026
Institutional Holders
102
13F filers
Shares Held
11.97M
Aggregate institutional
Institutional Value
$111.07M
Q1 2026
Net New Holders
+7
20 new · 13 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions20
Increased33
Decreased22
Sold out13
Institutional Holders
102 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 2.34M | $22.02M | 0 | Held |
| 2 | Orbimed Advisors LLC | 1.74M | $16.31M | +140.0K | Added |
| 3 | Aberdeen Group PLC | 1.32M | $12.41M | 0 | Held |
| 4 | Citadel Advisors LLC | 727.1K | $6.83M | −116.1K | Reduced |
| 5 | Prosight Management, LP | 697.1K | $6.55M | +13.2K | Added |
| 6 | Diadema Partners LP | 440.0K | $4.13M | +440.0K | New |
| 7 | Stonepine Capital Management, LLC | 383.5K | $3.60M | −6.5K | Reduced |
| 8 | Armistice Capital, LLC | 364.0K | $3.42M | −172.0K | Reduced |
| 9 | Renaissance Technologies LLC | 347.0K | $3.26M | −7.3K | Reduced |
| 10 | Susquehanna International Group, LLP | 333.4K | $3.13M | +105.6K | Added |
92 more institutional holders on Premium
See every fund holding Corbus Pharmaceuticals Hldgs, with full quarter-over-quarter share changes.
Unlock all holders